Merck & Co., Inc. Announces FDA Approves Merck's KEYTRUDA&#x

Merck & Co., Inc. announced the U.S. Food and Drug Administration has approved KEYTRUDA, Merck?s anti-PD-1 therapy, in combination with chemoradiotherapy for the treatment of patients with FIGO ...

Related Keywords

, Foundation Inc , Merck Co Inc , Drug Administration , International Federation Of Gynecology , European Network For Gynaecological Oncological Trial , International Federation , Combined Positive Score , European Network , Gynaecological Oncological Trial , Markets ,